AliveDx Suisse S.A. (AliveDx) is pleased to announce the signing of a strategic distribution agreement with Medical Supplies and Services Co. Ltd. (MediServ). This agreement enables MediServ to distribute the MosaiQ® and LumiQ® solutions across Saudi Arabia, with immediate effect.
This partnership marks a significant step in AliveDx’s ongoing commitment to expanding its presence in the Middle East and supporting healthcare providers with innovative diagnostic technologies. Through this collaboration, AliveDx aims to deliver clinical and economic value to clinicians by helping shorten time to diagnosis and improve patient outcomes. Transforming diagnostics with MosaiQ and LumiQ.
The MosaiQ and LumiQ platforms are designed to simplify laboratory workflows and enhance operational efficiency through fully automated, multiplex microarray assay technology. These platforms provide fast and cost-effective diagnostic solution, ultimately benefiting both healthcare providers and patients.
“We are proud to announce this partnership with yet another top-tier player in the Saudi Arabia market. We look forward to working with MediServ and playing a strategic role in improving patients’ lives in the region,” said Manuel O. Méndez, CEO of AliveDx.
“This agreement marks not only a significant milestone for both organizations but also holds deep personal meaning for me. As someone who spent a major part of my life in the Kingdom, I am thrilled to be working once again in a country that feels like home. Partnering with MediServ, a trusted leader in healthcare distribution, aligns perfectly with our mission at AliveDx to bring innovative diagnostic solutions to emerging markets. I look forward to the impact we will make together in advancing healthcare across Saudi Arabia” said Khaled Hamed, Head of Global Emerging Markets, AliveDx
About MediServ
Founded in 1980 in Riyadh, MediServ is a well-established, leader in Saudi healthcare sector, specialized in the supply, delivering a wide range of laboratory, medical and pharma products with strong logistics and service networks. With decades-long experience, strategic global partnerships with more than 50 to leading global brands, and a deep client base across public and private sectors—including government agencies and hospitals—it plays a pivotal role in the Kingdom’s healthcare infrastructure.
“We are honoured to collaborate with AliveDx. One of our group initiatives is to enrich our diagnostic business portfolio, having AliveDx solutions marks our expansion into the autoimmune diseases, allergy diagnostic segment and more to come. We believe MosaiQ and LumiQ will provide the Saudi Arabian healthcare sector with best-in-class technology that positively impact patient care which is aligned with MediServ’s vision and plans to contribute to the Kingdom’s ambitious goals for healthcare transformation. By enhancing accessibility, improving efficiency, and fostering innovation, we align our mission with the nation’s vision of a more advanced and sustainable healthcare system. This alignment is not just a corporate goal but a shared responsibility to support the well-being of our nation,” stated Omar bin Humaid, CEO, MediServ.
“We are transforming and diversifying our operations, portfolio and solutions through partnering with cutting-edge technologies providers like AliveDx to support Saudi healthcare vision 2030 of better quality of care and better patient outcomes,” said Nabil Iweir, CBEO, MediServ
To learn more, visit:
- https://mediserv.com.sa/
- AliveDx
